BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 32826856)

  • 1. ARNTL2 promotes pancreatic ductal adenocarcinoma progression through TGF/BETA pathway and is regulated by miR-26a-5p.
    Wang Z; Liu T; Xue W; Fang Y; Chen X; Xu L; Zhang L; Guan K; Pan J; Zheng L; Qin G; Wang T
    Cell Death Dis; 2020 Aug; 11(8):692. PubMed ID: 32826856
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LncRNA PCAT6 promotes the proliferation, migration and invasion of pancreatic ductal adenocarcinoma via regulating miR-185-5p/CBX2 axis.
    Wang W; Li X; Guan C; Hu Z; Zhao Y; Li W; Jiang X
    Pathol Res Pract; 2020 Sep; 216(9):153074. PubMed ID: 32825947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulated miR-98-5p promotes PDAC proliferation and metastasis by reversely regulating MAP4K4.
    Fu Y; Liu X; Chen Q; Liu T; Lu C; Yu J; Miao Y; Wei J
    J Exp Clin Cancer Res; 2018 Jul; 37(1):130. PubMed ID: 29970191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-628-5p inhibits invasion and migration of human pancreatic ductal adenocarcinoma via suppression of the AKT/NF-kappa B pathway.
    Zhou L; Jiao X; Peng X; Yao X; Liu L; Zhang L
    J Cell Physiol; 2020 Nov; 235(11):8141-8154. PubMed ID: 31957029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-561-5p Inhibits Cell Proliferation and Invasion by Targeting RAC1 in Pancreatic Ductal Adenocarcinoma.
    Xi B; Lai M; Zhang W; Wang F
    Ann Clin Lab Sci; 2022 Mar; 52(2):213-221. PubMed ID: 35414500
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage-derived exosomal microRNA-501-3p promotes progression of pancreatic ductal adenocarcinoma through the TGFBR3-mediated TGF-β signaling pathway.
    Yin Z; Ma T; Huang B; Lin L; Zhou Y; Yan J; Zou Y; Chen S
    J Exp Clin Cancer Res; 2019 Jul; 38(1):310. PubMed ID: 31307515
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circular RNA circBFAR promotes the progression of pancreatic ductal adenocarcinoma via the miR-34b-5p/MET/Akt axis.
    Guo X; Zhou Q; Su D; Luo Y; Fu Z; Huang L; Li Z; Jiang D; Kong Y; Li Z; Chen R; Chen C
    Mol Cancer; 2020 May; 19(1):83. PubMed ID: 32375768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MiR-708-5p inhibits the progression of pancreatic ductal adenocarcinoma by targeting Sirt3.
    Huang S; Guo H; Cao Y; Xiong J
    Pathol Res Pract; 2019 Apr; 215(4):794-800. PubMed ID: 30683474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-323-3p inhibits cell invasion and metastasis in pancreatic ductal adenocarcinoma via direct suppression of SMAD2 and SMAD3.
    Wang C; Liu P; Wu H; Cui P; Li Y; Liu Y; Liu Z; Gou S
    Oncotarget; 2016 Mar; 7(12):14912-24. PubMed ID: 26908446
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Upregulated circular RNA circ_0007534 indicates an unfavorable prognosis in pancreatic ductal adenocarcinoma and regulates cell proliferation, apoptosis, and invasion by sponging miR-625 and miR-892b.
    Hao L; Rong W; Bai L; Cui H; Zhang S; Li Y; Chen D; Meng X
    J Cell Biochem; 2019 Mar; 120(3):3780-3789. PubMed ID: 30382592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of Oncogenic Targets Controlled by Tumor-Suppressive
    Nepal P; Hozaka Y; Tanaka T; Wada M; Asai S; Minemura C; Idichi T; Arigami T; Kurahara H; Seki N; Ohtsuka T
    Anticancer Res; 2021 Oct; 41(10):4821-4836. PubMed ID: 34593431
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nicotine promotes tumor progression and epithelial-mesenchymal transition by regulating the miR-155-5p/NDFIP1 axis in pancreatic ductal adenocarcinoma.
    Ben Q; Sun Y; Liu J; Wang W; Zou D; Yuan Y
    Pancreatology; 2020 Jun; 20(4):698-708. PubMed ID: 32354626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiRNA-615-5p functions as a tumor suppressor in pancreatic ductal adenocarcinoma by targeting AKT2.
    Sun Y; Zhang T; Wang C; Jin X; Jia C; Yu S; Chen J
    PLoS One; 2015; 10(4):e0119783. PubMed ID: 25856297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-615-5p is epigenetically inactivated and functions as a tumor suppressor in pancreatic ductal adenocarcinoma.
    Gao W; Gu Y; Li Z; Cai H; Peng Q; Tu M; Kondo Y; Shinjo K; Zhu Y; Zhang J; Sekido Y; Han B; Qian Z; Miao Y
    Oncogene; 2015 Mar; 34(13):1629-40. PubMed ID: 24769899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. circNFIB1 inhibits lymphangiogenesis and lymphatic metastasis via the miR-486-5p/PIK3R1/VEGF-C axis in pancreatic cancer.
    Kong Y; Li Y; Luo Y; Zhu J; Zheng H; Gao B; Guo X; Li Z; Chen R; Chen C
    Mol Cancer; 2020 May; 19(1):82. PubMed ID: 32366257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MiR-10b inhibits migration and invasion of pancreatic ductal adenocarcinoma via regulating E2F7.
    Xu C; Qi X
    J Clin Lab Anal; 2020 Oct; 34(10):e23442. PubMed ID: 32592206
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular pathogenesis of pancreatic ductal adenocarcinoma: Impact of passenger strand of pre-miR-148a on gene regulation.
    Idichi T; Seki N; Kurahara H; Fukuhisa H; Toda H; Shimonosono M; Okato A; Arai T; Kita Y; Mataki Y; Kijima Y; Maemura K; Natsugoe S
    Cancer Sci; 2018 Jun; 109(6):2013-2026. PubMed ID: 29660218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA H19/miR-194/PFTK1 axis modulates the cell proliferation and migration of pancreatic cancer.
    Sun Y; Zhu Q; Yang W; Shan Y; Yu Z; Zhang Q; Wu H
    J Cell Biochem; 2019 Mar; 120(3):3874-3886. PubMed ID: 30474270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The MYEOV-MYC association promotes oncogenic miR-17/93-5p expression in pancreatic ductal adenocarcinoma.
    Shen H; Ye F; Xu D; Fang L; Zhang X; Zhu J
    Cell Death Dis; 2021 Dec; 13(1):15. PubMed ID: 34930894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CircNEIL3 regulatory loop promotes pancreatic ductal adenocarcinoma progression via miRNA sponging and A-to-I RNA-editing.
    Shen P; Yang T; Chen Q; Yuan H; Wu P; Cai B; Meng L; Huang X; Liu J; Zhang Y; Hu W; Miao Y; Lu Z; Jiang K
    Mol Cancer; 2021 Mar; 20(1):51. PubMed ID: 33750389
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.